Taha Kass-Hout (@drtaha_fda) 's Twitter Profile
Taha Kass-Hout

@drtaha_fda

follow me @kasshout || CTO of @GEHealthcare, Ex. VP & CMO @awscloud, HealthLake, Comprehend Medical. Adv Board @FredHutch. CHIO @US_FDA, @openFDA @precisionFDA

ID: 1513753861

linkhttps://www.linkedin.com/in/tahak calendar_today13-06-2013 15:41:32

1,1K Tweet

1,1K Followers

4 Following

precisionFDA (@precisionfda) 's Twitter Profile Photo

The PacBio and Oxford Nanopore (Guppy v3.6) datasets are now available for the precisionFDA Truth Challenge V2. To accommodate analysis of these datasets we have extended the submission deadline for the challenge to June 8th go.usa.gov/xvsnv

The PacBio and Oxford Nanopore (Guppy v3.6) datasets are now available for the precisionFDA Truth Challenge V2. To accommodate analysis of these datasets we have extended the submission deadline for the challenge to June 8th go.usa.gov/xvsnv
Taha Kass-Hout (@kasshout) 's Twitter Profile Photo

Activating artificial intelligence ⁦Amazon Web Services⁩ in the fight against #Covid - highlighted by ⁦Swami Sivasubramanian⁩. And for all your research questions, visit our explorer cord19.aws ⁦World Economic Forum⁩ ⁦#ai weforum.org/agenda/2020/05…

Taha Kass-Hout (@drtaha_fda) 's Twitter Profile Photo

. openFDA recently stood up this special public #API for independent evaluations of #COVID19 serological tests by the U.S. FDA and NIH open.fda.gov/apis/device/co…

Taha Kass-Hout (@drtaha_fda) 's Twitter Profile Photo

Over 250M requests served by ⁦openFDA⁩ since we launched it in 2014, including drug adverse events, cosmetic products adverse reactions, animal pet food recalls, tracking medical device implants, and more... open.fda.gov/about/statisti…

Taha Kass-Hout (@kasshout) 's Twitter Profile Photo

Looking for therapeutic equivalence is as simple as an API call to openFDA’s new medical product endpoint (some data going as far back as 1939) kudos to Lonnie Smith at the U.S. FDA for shepherding this effort

Taha Kass-Hout (@kasshout) 's Twitter Profile Photo

Yesterday, we introduced Amazon #HealthLake during Swami Sivasubramanian #MachineLearning keynote at AWS re:Invent. In our blog here, Dr. mza and I explain the significance of this new service and why healthcare and life sciences customers are excited about it. aws.amazon.com/blogs/machine-…

Taha Kass-Hout (@kasshout) 's Twitter Profile Photo

13,352 adverse events related to #covid19 reported to the U.S. FDA in 2020. Here is the top list of associated drug classes retrieved from openFDA (notice IL6) api.fda.gov/drug/event.jso…

13,352 adverse events related to #covid19 reported to the <a href="/US_FDA/">U.S. FDA</a> in 2020. Here is the top list of associated drug classes retrieved from <a href="/openFDA/">openFDA</a> (notice IL6)

api.fda.gov/drug/event.jso…
precisionFDA (@precisionfda) 's Twitter Profile Photo

Check out our new Featured Expert blog post and learn about the importance of synthetic data and how it is being used to inform Veteran healthcare: go.usa.gov/xstrA #syntheticdata #VeteranHealth #COVID19 #AIforCOVID

Miguel C (@m_karmona) 's Twitter Profile Photo

In terms of data, we use Scala and Apache Spark as the main drivers for aggregating +40 datasets, analysing openFDA FAERS, processing Europe PMC articles literature using SparkNLP from JohnSnowLabs and producing ML models. x.com/d0choa/status/…

Taha Kass-Hout (@kasshout) 's Twitter Profile Photo

Really great to see openFDA continues to provide value to the public, in this case target and drug discovery. Congrats to the Open Targets team on achieving a new milestone U.S. FDA

Wellcome Sanger Institute (@sangerinstitute) 's Twitter Profile Photo

📰 Read “Exploring bacterial diversity via a curated and searchable snapshot of archived DNA sequences” from Wellcome Sanger Institute EMBL-EBI in PLOS Biology ⤵️ journals.plos.org/plosbiology/ar…

HealthTech Magazine (@healthtechmag) 's Twitter Profile Photo

#AI in #healthcare is evolving. Read more about the current state of artificial intelligence in healthcare and where it’s headed in 2023: healthtechmagazine.net/article/2022/1…